2- and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors

Purinergic Signalling

Volumn 1, Issue 2, 2005, Pages 173-181

  Volpini, Rosaria ^a   Costanzi, Stefano ^a   Lambertucci, Catia ^a   Vittori, Sauro ^a   Martini, Claudia ^b   Trincavelli, M Letizia ^c   Klotz, Karl Norbert ^c   Cristalli, Gloria ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenosine; Adenosine antagonists; Adenosine receptors; Antagonist; Purine derivatives; Substituted adenines

Indexed keywords

ADENOSINE RECEPTORS; AFFINITY; ALKYNYL CHAINS; BINDING ASSAYS; BIOLOGICAL ACTIVITY; ETHYLADENINE DERIVATIVES;

2 CYCLOHEXYLETHYNYL 9 ETHYL 9H PURIN 6 YLAMINE; 3 (6 AMINO 9 ETHYL 9H PURIN 2 YL) 1 PHENYLPROP 2 YN 1 OL; 9 ETHYL 2 PHENYLETHYNYL 9H PURIN 6 YLAMINE; ADENINE DERIVATIVE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENYLATE CYCLASE; ALKYL GROUP; ALKYNYL GROUP; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; RHODOPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; MOLECULAR MODEL; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 16344392751     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-005-6216-y     Document Type: Article

References (29)

1. Poulsen SA, Quinn RJ. Adenosine receptors: New opportunity for future drugs. Bioorg Med Chem 1998; 6: 619-41.
2. Robeva AS, Woodard RL, Ji XD et al. Drug Develop Res 1996; 39: 243-52.
3. Fredholm BB, IJzerman AP, Klotz K-N, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-33.
4. Fredholm BB, Arslan G, Halldner L et al. Structure and function of adenosine receptors and their genes. Naunyn Schmiedeberg's Arch Pharmacol 2000; 362: 364-74.
5. 3 Adenosine receptor antagonists. Mini Rev Med Chem 2001; 1: 433-43.
6. 2 receptor ligands. Curr Topics Med Chem 2003; 3: 345-462.
7. Adenosine receptors: Medicinal chemistry, pharmacology and therapeutic applications. In Cristalli, G, Volpini R (eds): Curr Topics Med Chem 2003; 3: 355-469.
8. Hess S. Recent advances in adenosine receptor antagonist research. Expert Opin Ther Patents 2001; 11: 1-29.
9. Müller CE, Stein B. Adenosine receptor antagonists: Structure and potential therapeutic applications. Curr Pharm Des 1996; 2: 501-30.
10. 2 adenosine receptors. J Med Chem 1992; 35: 2363-8.
11. 2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J Med Chem 1994; 37: 1720-6.
12. 2a adenosine receptor agonists. J Med Chem 1995; 38: 1462-72.
13. Camaioni E, Di Francesco E, Vittori S et al. Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1yl)NECA. Bioorg Med Chem 1997; 5: 2267-75.
14. 2B ligands. J Med Chem 2002; 45: 3271-3279.
15. Volpini R, Costanzi S, Lambertucci C et al. Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists. Curr Pharm Design 2002; 8: 99-110.
16. 2 adenosine receptor. Bioorg Med Chem Lett 2001; 11: 1931-4.
17. 3 receptor can explain their different biological behavior. J Mol Graph Model 2003; 21: 253-62.
18. Camaioni E, Costanzi S, Vittori S et al. New substituted 9-alkylpurines as adenosine receptor ligands. Bioor Med Chem 1998; 6: 523-33.
19. Cristalli G, Camaioni E, Costanzi S et al. Characterization of potent ligands at human recombinant adenosine receptors. Drug Dev Res 1998; 45: 176-81.
20. Klotz KN, Kachler S, Lambertucci C et al. 9-Ethyladenine derivatives as adendosine receptor antagonists: 2- and 8-substitution results in distinct selectivities. Naunyn-Schmiedeberg's Arch Pharmacol 2003; 367: 629-34.
21. 1-adenosine receptor antagonist. Fed Am Soc Exp Biol J 1991; 5: 572.
22. 2B receptor. J Med Chem 2001; 44: 170-9.
23. 1 receptor. Bioorg Med Chem 2004; 12: 139-49.
24. Klotz KN, Hessling J, Hegler J et al. Comparative pharmacology of human adenosine subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch Pharmacol 1998; 357: 1-9.
25. De Lean A, Hancock AA, Lefkowitz RJ. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 1982; 21: 5-16.
26. Colotta V, Catarzi D, Varano F et al. 1,2,4-Triazolo[4,3-a] quinoxalin-1-one: A versatile tool for the synthesis of potent and selective adenosine receptor antagonists. J Med Chem 2000; 43: 1158-64.
27. 50) of an enzyme reaction. Biochem Pharmacol 1973; 22: 3099-108. 10.1016/0006-2952(73)90196-2
28. Cornell WD, Cieplak P, Bayly CI et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 1995; 117: 5179-97.
29. 2B adenosine receptors. Curr Topics Med Chem 2003; 3: 427-43.